Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Net Margin (2022 - 2025)

Historic Net Margin for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to 356.86%.

  • TriSalus Life Sciences' Net Margin fell 3132900.0% to 356.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 179.71%, marking a year-over-year increase of 388800.0%. This contributed to the annual value of 112.92% for FY2024, which is 2306700.0% up from last year.
  • TriSalus Life Sciences' Net Margin amounted to 356.86% in Q3 2025, which was down 3132900.0% from 80.28% recorded in Q2 2025.
  • TriSalus Life Sciences' Net Margin's 5-year high stood at 36.26% during Q3 2023, with a 5-year trough of 786.45% in Q4 2022.
  • Over the past 4 years, TriSalus Life Sciences' median Net Margin value was 206.3% (recorded in 2022), while the average stood at 257.09%.
  • In the last 5 years, TriSalus Life Sciences' Net Margin soared by 5051000bps in 2024 and then plummeted by -3132900bps in 2025.
  • TriSalus Life Sciences' Net Margin (Quarter) stood at 786.45% in 2022, then rose by 19bps to 636.93% in 2023, then surged by 79bps to 131.84% in 2024, then plummeted by -171bps to 356.86% in 2025.
  • Its last three reported values are 356.86% in Q3 2025, 80.28% for Q2 2025, and 120.94% during Q1 2025.